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Introduction
The allogeneic bone marrow transplantation is a thera-
peutic weapon for treating severe and drug-resistant
autoimmune diseases determining the resolution and
improvement in the quality of life. On the other hand
autoimmune disorders can develop after a hematopoietic
stem cell transplantation (HSCT).
Objectives
AF came to our attention when she was 14 years old for
swelling and pain (8 at the Numeric Rating Scale) in the
proximal interphalangeal (IFP) joint of the II and III finger
of the right hand, painful IFP of the III finger of the left
hand accompanied by morning stiffness which lasted for
2 hours and swelling with functional impairment of hands,
wrists and knees.
Blood count showed increased inflammatory indexes,
antinuclear antibody (ANA) positivity (1:640 in Hep2
cells) and rheumatoid factor negative. The RM of the
hands showed endoarticular fluid in both carpal bones and
in the radioulnar joint with signs of synovitis; synovitis
alone was also present in metacapophalangeal joint of the
II, III and IV finger of the left hand and II and III on the
right, IFP of III finger left and II and III right, carpometa-
carpal joint of the I finger bilaterally. This clinical findings
were characteristic of Juvenile Idiopathic Arthritis polyarti-
cular rheumatoid factor negative subtype according to the
ILAR classification.
The past medical history of our young girl was particu-
larly important. When she was 18 month old, she was
diagnosed of acute lymphoblastic leukemia and started
chemotherapy according to AEIOP LAL 9502 protocol.
One month after the re-induction phase she presented a
disease relapse in the bone marrow so she started a
chemotherapy cycle of second degree and the research for
an unrelated donor because no familiar HLA-matched
donor was present. When she was 3 years old, she under-
went hematopoietic stem cells transplantation of periph-
eral-derived source. Ten months later, during the tapering
of immunosuppressive therapy, she presented skin lesions
resembling chronic GVHD so she started again immuno-
suppressive therapy with tacrolimus and mycophenolate
mofetil. Later she developed restrictive respiratory
syndrome, ovarian insufficiency in replacement therapy
and a thyroiditis ultrasonography aspect without hormonal
alterations.
This important personal history challenged us in the
choice of therapy. She started with NSAID (Naproxen)
with only partial relief. For the severe polyarticular invol-
vement, after the discussion with the hematologists, we
decided to introduce a steroid agent. The girl had a good
response but, during steroid tapering, pain and functional
impairment of legs and arms reappeared with morning
stiffness and swelling of hands. For this reason we finally
decided to start Methotrexate.
Conclusion
We don’t know exactly if juvenile idiopathic arthritis in
our patient is a de novo autoimmune disease induced by
the transfer of a heterologous immunological system or a
rare presentation of graft-versus-host-disease, however
MTX therapy was effective and improved the symptoma-
tology with a complete remission after 2 months.
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